The Impact of Steatosis on Chronic Hepatitis C Progression and Response to Antiviral Treatments
出版年份 2021 全文链接
标题
The Impact of Steatosis on Chronic Hepatitis C Progression and Response to Antiviral Treatments
作者
关键词
-
出版物
Biomedicines
Volume 9, Issue 10, Pages 1491
出版商
MDPI AG
发表日期
2021-10-18
DOI
10.3390/biomedicines9101491
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Chronic hepatitis C infection induces cardiovascular disease and type 2 diabetes: mechanisms and management
- (2021) Riccardo NEVOLA et al. MINERVA MEDICA
- Extrahepatic Manifestations of Chronic HCV Infection
- (2021) Patrice Cacoub et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metabolic complications of hepatitis C virus infection
- (2021) Rahul Chaudhari et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Hepatitis C Virus Uses Host Lipids to Its Own Advantage
- (2021) Malgorzata Sidorkiewicz Metabolites
- Comparison of liver biopsies before and after direct-acting antiviral therapy for hepatitis C and correlation with clinical outcome
- (2021) Omar A. Saldarriaga et al. Scientific Reports
- Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study
- (2020) Luigi Elio Adinolfi et al. ATHEROSCLEROSIS
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- The association between metabolic syndrome and Hepatitis C virus infection in the United States
- (2020) Preetha Rajkumar et al. CANCER CAUSES & CONTROL
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct‐acting antivirals therapy. A prospective study.
- (2020) Luigi E Adinolfi et al. DIABETES OBESITY & METABOLISM
- Correlation between the small dense LDL level and nonalcoholic fatty liver disease
- (2020) Ha Won Hwang et al. MEDICINE
- Persistent augmentation of central arterial stiffness following viral clearance by direct‐acting antivirals in chronic hepatitis C
- (2020) Ju‐Yi Chen et al. JOURNAL OF VIRAL HEPATITIS
- Diabetes poses a higher risk of hepatocellular carcinoma and mortality in patients with chronic hepatitis B: A population-based cohort study
- (2019) Yu-Chiau Shyu et al. JOURNAL OF VIRAL HEPATITIS
- Virus Genotype-Dependent Transcriptional Alterations in Lipid Metabolism and Inflammation Pathways in the Hepatitis C Virus-infected Liver
- (2019) W. M. H. d’Avigdor et al. Scientific Reports
- Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis
- (2019) Jie Li et al. Lancet Gastroenterology & Hepatology
- Direct-acting antivirals improve endothelial function in patients with chronic hepatitis: a prospective cohort study
- (2019) Matteo Nicola Dario Di Minno et al. Internal and Emergency Medicine
- Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study
- (2019) Luca Rinaldi et al. Journal of Translational Medicine
- Non-alcoholic fatty liver disease in adults: Current concepts in etiology, outcomes and management
- (2019) Thomas Marjot et al. ENDOCRINE REVIEWS
- Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
- (2018) David Højland Ipsen et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis
- (2018) Nicole E. Rich et al. Clinical Gastroenterology and Hepatology
- Nonalcoholic Fatty Liver Disease and Metabolic Syndrome
- (2018) Donghee Kim et al. Clinics in Liver Disease
- Changes in liver stiffness and steatosis among patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response
- (2018) Natsuko Kobayashi et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Hepatitis C virus clearance by direct-acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients
- (2018) Luigi E Adinolfi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis
- (2018) Salvatore Petta et al. JOURNAL OF HEPATOLOGY
- Predictors of treatment efficacy and liver stiffness changes following therapy with Sofosbuvir plus Ribavirin in patients infected with HCV genotype 2
- (2018) Kazuki Ohya et al. JOURNAL OF MEDICAL VIROLOGY
- Elevated body mass index is a risk factor associated with possible liver cirrhosis across different etiologies of chronic liver disease
- (2018) Yi-Hao Yen et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Triggering and resolution of inflammation in NASH
- (2018) Susanne Schuster et al. Nature Reviews Gastroenterology & Hepatology
- Association between chronic viral hepatitis and metabolic syndrome in southern Taiwan: a large population-based study
- (2018) Yuan-Hung Kuo et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Updates in the management and treatment of HCV genotype 3, what are the remaining challenges?
- (2018) Jee-Fu Huang et al. Expert Review of Anti-Infective Therapy
- Direct-acting Antiviral Therapy for HCV Infection is Associated with a Reduced Risk of Cardiovascular Disease Events
- (2018) Adeel A. Butt et al. GASTROENTEROLOGY
- Modulation of Insulin Resistance in NAFLD
- (2018) Reenam Khan et al. HEPATOLOGY
- Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents
- (2018) Alessandro Gualerzi et al. PLoS One
- Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis
- (2018) Naoki Kawagishi et al. PLoS One
- Ribavirin augments doxorubicin's efficacy in human hepatocellular carcinoma through inhibiting doxorubicin-induced eIF4E activation
- (2017) Jun Tan et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan
- (2017) Goki Suda et al. JOURNAL OF GASTROENTEROLOGY
- Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment
- (2017) Vincent Wai-Sun Wong et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Serial changes in liver stiffness and controlled attenuation parameter following direct-acting antiviral therapy against hepatitis C virus genotype 1b
- (2017) Nobuhiko Ogasawara et al. JOURNAL OF MEDICAL VIROLOGY
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Diabetes mellitus is a significant risk factor for the development of liver cirrhosis in chronic hepatitis C patients
- (2017) Xu Li et al. Scientific Reports
- Insulin Resistance the Link between T2DM and CVD: Basic Mechanisms and Clinical Implications
- (2017) Muhammad A. Abdul-Ghani et al. Current Vascular Pharmacology
- Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease
- (2016) Alessandro Mantovani et al. DIGESTIVE DISEASES AND SCIENCES
- Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies
- (2016) Salvatore Petta et al. GASTROENTEROLOGY
- Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden
- (2016) Zobair Younossi et al. GASTROENTEROLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- The independent predictors of non-alcoholic steatohepatitis and its individual histological features.
- (2016) Stefano Ballestri et al. HEPATOLOGY RESEARCH
- Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis
- (2016) Stefano Ballestri et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
- (2016) Fabio Conti et al. JOURNAL OF HEPATOLOGY
- Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
- (2016) María Reig et al. JOURNAL OF HEPATOLOGY
- Anti-adipogenic and antiviral effects ofl-carnitine on hepatitis C virus infection
- (2016) Yoko Tsukuda et al. JOURNAL OF MEDICAL VIROLOGY
- Metabolic syndrome and subsequent risk of type 2 diabetes and cardiovascular disease in elderly women
- (2016) Katrine Dragsbæk et al. MEDICINE
- Non-alcoholic fatty liver disease and risk of cardiovascular disease
- (2016) Amedeo Lonardo et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV
- (2016) Amedeo Lonardo et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Hepatitis C Virus Increases Free Fatty Acids Absorption and Promotes its Replication Via Down-Regulating GADD45α Expression
- (2016) Wei Chen et al. MEDICAL SCIENCE MONITOR
- Rapid Increase in Serum Low-Density Lipoprotein Cholesterol Concentration during Hepatitis C Interferon-Free Treatment
- (2016) Satoru Hashimoto et al. PLoS One
- Liver fat, statin use, and incident diabetes: The Multi-Ethnic Study of Atherosclerosis
- (2015) Ravi V. Shah et al. ATHEROSCLEROSIS
- Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
- (2015) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients
- (2015) Eric G. Meissner et al. HEPATOLOGY
- Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
- (2015) Stuart McPherson et al. JOURNAL OF HEPATOLOGY
- The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals
- (2015) Takuya Fukuda et al. LIVER INTERNATIONAL
- Steatosis and hepatitis C
- (2015) Jamak Modaresi Esfeh et al. Gastroenterology Report
- The Effect of PNPLA3 on Fibrosis Progression and Development of Hepatocellular Carcinoma: A Meta-analysis
- (2014) Amit G Singal et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Small Dense Low-Density Lipoprotein-Cholesterol Concentrations Predict Risk for Coronary Heart Disease
- (2014) Ron C. Hoogeveen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV
- (2014) Fasiha Kanwal et al. HEPATOLOGY
- Suppression of hepatocellular carcinoma development in hepatitis C patients given interferon-based antiviral therapy
- (2014) Naoki Hiramatsu et al. HEPATOLOGY RESEARCH
- Interaction between hepatitis C virus and metabolic factors
- (2014) Yasunori Kawaguchi WORLD JOURNAL OF GASTROENTEROLOGY
- Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen
- (2014) Amedeo Lonardo WORLD JOURNAL OF GASTROENTEROLOGY
- Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease
- (2014) Amedeo Lonardo et al. Expert Review of Gastroenterology & Hepatology
- Obesity-Associated Nonalcoholic Fatty Liver Disease
- (2013) Yusuf Yilmaz et al. Clinics in Liver Disease
- Association between hepatic steatosis and hepatic expression of genes involved in innate immunity in patients with chronic hepatitis C
- (2013) Hidenori Toyoda et al. CYTOKINE
- Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
- (2013) Adriaan J. van der Meer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hepatitis C Virus Stimulates Low-Density Lipoprotein Receptor Expression To Facilitate Viral Propagation
- (2013) G. H. Syed et al. JOURNAL OF VIROLOGY
- Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2
- (2012) K. D. Copps et al. DIABETOLOGIA
- Ribavirin modulates the conversion of human CD4+ CD25−T cell to CD4+ CD25+ FOXP3+T cell via suppressing interleukin-10-producing regulatory T cell
- (2012) Tamaki Kobayashi et al. IMMUNOLOGY
- Myocardial injury in patients with chronic hepatitis C infection
- (2012) Shigeo Maruyama et al. JOURNAL OF HEPATOLOGY
- Steatosis and insulin resistance in response to treatment of chronic hepatitis C
- (2012) F. Negro JOURNAL OF VIRAL HEPATITIS
- Free fatty acids induce ER stress and block antiviral activity of interferon alpha against hepatitis C virus in cell culture
- (2012) Feyza Gunduz et al. Virology Journal
- Steatosis Is an Independent Predictor of Relapse Following Rapid Virologic Response in Patients With HCV Genotype 3
- (2011) Samir R. Shah et al. Clinical Gastroenterology and Hepatology
- Down-regulation of phosphatase and tensin homolog by hepatitis C virus core 3a in hepatocytes triggers the formation of large lipid droplets
- (2011) Sophie Clément et al. HEPATOLOGY
- Steatosis is the predictor of relapse in HCV genotype 3- but not 2-infected patients treated with 12 weeks of pegylated interferon-α-2a plus ribavirin and RVR
- (2011) L. Restivo et al. JOURNAL OF VIRAL HEPATITIS
- HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis
- (2011) G. Nkontchou et al. JOURNAL OF VIRAL HEPATITIS
- Steatohepatitic Hepatocellular Carcinoma (SH-HCC)
- (2010) Marcela Salomao et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis
- (2010) Mahwish Khan et al. ARCHIVES OF VIROLOGY
- Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy
- (2010) Masayuki Kurosaki et al. HEPATOLOGY RESEARCH
- The impact of hepatic steatosis on the natural history of chronic hepatitis C infection
- (2009) T. J. S. Cross et al. JOURNAL OF VIRAL HEPATITIS
- All-Cause and Cardiovascular Mortality Using the Different Definitions of Metabolic Syndrome
- (2008) Athanase Benetos et al. AMERICAN JOURNAL OF CARDIOLOGY
- Metabolic Syndrome and Incident Diabetes: Current state of the evidence
- (2008) E. S. Ford et al. DIABETES CARE
- Activation of sterol regulatory element-binding protein 1c and fatty acid synthase transcription by hepatitis C virus non-structural protein 2
- (2008) J.-K. Oem et al. JOURNAL OF GENERAL VIROLOGY
- Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C
- (2007) Matteo Vidali et al. JOURNAL OF HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More